• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA commissioner on drug approvals: The problem isn't innovation or speed

cafead

Administrator
Staff member
  • cafead   Dec 08, 2022 at 11:32: PM
via There’s “no question” that the US is the top pharma innovator for the world, FDA commissioner Robert Califf said yesterday at the Milken Institute’s Future of Health Summit, but he also pointed to the falling life expectancy in the US, which is now five years shorter than some other high-income countries.

article source